Current Studies


Artificial Pancreas

Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index
(Detailed Study Information)
The International Diabetes Closed Loop (iDCL) Trial: Main Protocol (iDCL Main)
(Detailed Study Information)
International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol
 (Detailed Study Information)

If you would like to be in an AP study, please contact:
Laura Lindsey
805-682-7640 ext. 221

Additional Studies
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
(Detailed Study Information)
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes (onset®8)
 (Detailed Study Information)
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
(Detailed Study Information)

If you would like to be in one of these studies, please contact:
Donna Frase
805-682-7640 ext 255

TrialNet Pathway to Prevention Study (TN-01)
Detailed Study Information)

If you would like to be in a TrialNet study, please contact:
Eric Ambriz
805-682-7640 ext. 209

All clinical trials are conducted at our site in Santa Barbara, California. To participate, you will need to come to our site in person. Eligibility for a clinical trial is determined by the study investigator and/or research coordinator. All research is approved by an Institutional Review Board (IRB). Details of many studies can be found on